The Utility of FDG-PET for Radiation Treatment in NSCLC

The Utility of 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for Radiation Treatment Planning in Non-Small Cell Lung Cancer (NSCLC)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00385164

Enrollment

Registered

2006-10-06

Start date

2006-10-31

Completion date

Unknown

Last updated

2017-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms, Positron Emission Tomography

Keywords

lung neoplasms, positron emissions tomography, radiotherapy planning

Brief summary

Patients planned for radical radiation for NSCLC will undergo conventional CT stimulation and also PET/CT scans for definition of radiation target volumes

Interventions

PROCEDUREPET/CT scan for RT planning

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Non-small cell lung cancer to receive radical radiation

Exclusion criteria

* unable to tolerate PET/CT scan

Countries

Canada

Contacts

Primary ContactHarold P Lau, MD

403-521-3012

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026